Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Typhoon Highly Prospective for New Gold Discovery, Drilling the Prolific Porcupine-Destor Break

Typhoon Exploration Inc. (TSX-V: TYP) (US Listing: TYPFF) (Berlin: TPH1) is the subject of a Mining MarketWatch Journal review, the full review with complete graphics may be seen at https://miningmarketwatch.net/typ.htm online. Typhoon Exploration is a Canadian-based mine...
James O'Rourke | October 2, 2020 |

Precipitate Gold Prepares to Drill Next to Pueblo Viejo

We are in the best time of the year to be invested in resource stocks. That is from late December into perhaps March. Add to that a quite insane U.S. President eager to accelerate the start of World War III for Israel and you have what at least will be an interesting en...
Streetwise Reports | January 7, 2020 |

Nicola Mining produces copper, silver, gold – with current cash flow – in prolific B.C.

By Peter Epstein Last week Nicola Mining Inc. (TSXV:NIM) (OTCQX:HUSIF) announced positive operating cash flow from its innovative business operations, which include a permitted gravel pit and rock quarry, and gravel, ash and soil segments, and an operating gold/si...
Research | August 23, 2023 |

MEI Pharma Shares Rise 50% on $682.5M Partnership with Japanese Company to Treat B-cell Malignancies

Shares of MEI Pharma traded higher after the company announced that it has entered into development and global licensing agreement with Kyowa Kirin for its oral selective PI3Kd inhibitor (ME-401) used for treating B-cell malignancies. Late-stage pharmaceutic...
Streetwise Reports | April 15, 2020 |

BioNTech, CureVac, EXMceuticals - reaching their goal with government support

In the fight against the spread of the Corona Pandemic, a great deal of commitment is required from companies. This situation also offers the opportunity to rethink and change existing work processes and procedures. Product ranges are being expanded and new possibilities and a...
Mario Hose | September 18, 2020 |

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation

Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps. The European Medicines Agency's Committee for Medicinal Produc...
Streetwise Reports | September 24, 2019 |

RingCentral's Partnership with Avaya Sends Both Firms Shares Up 25%

Shares of RingCentral and Avaya Holdings are soaring today after the announcement that RingCentral will become Avaya's exclusive Unified Communications as a Service (UCaaS) solutions provider. Yesterday afternoon after the markets closed, RingCentral Inc. (RNG:NYSE) ...
Streetwise Reports | October 8, 2019 |

Akcea Therapeutics Inks Worldwide Licensing Deal with Pfizer...

Akcea Therapeutics Inks Worldwide Licensing Deal with Pfizer for Investigative Antisense Therapy, Shares Up 30% Akcea Therapeutics' shares are trading 30% higher today on news that it has entered into a worldwide exclusive licensing agreement with Pfizer for AKCEA-ANG...
Streetwise Reports | October 8, 2019 |

Nemaura Medical Accelerates Launch of sugarBEAT Wearable Continuous Glucose Monitor

Shares of Nemaura Medical traded 20% higher after the firm reported that it is investigating using its non-invasive continuous glucose monitor sugarBEAT® jointly with its planned health subscription service BEAT®diabetes, to provide personalized lifestyle c...
Streetwise Reports | February 27, 2020 |

Allogene Therapeutics Shares Climb 30% on Phase 1 Relapsed/Refractory NHL Study Data

Shares of Allogene Therapeutics traded higher and reached a new 52-week high price after the company reported initial results from its Phase 1 relapsed/refractory non-Hodgkin lymphoma trial. Clinical-stage biotechnology company Allogene Therapeutics Inc. (ALLO:NAS...
Streetwise Reports | May 15, 2020 |
1 2 3 4 5 6 7 8 9 10 ...